Mobile Tool to Reduce HIV Stigma and Support PrEP Use
Tests mobile programs reducing HIV stigma in HIV-negative Thai young adults aged 18 to 29.
Plain-language title generated from the registry record
Registry title: Thailand HIV and Stigma Reduction Study
Key facts
- Where
- Bangkok, ThailandSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 29 years old?
Source: NCT06576648, who can take part
Where in Thailand
- Institute of HIV Research and InnovationBangkok, ThailandTaking people
- Rainbow Sky Association of ThailandBangkok, ThailandTaking people
- SWING FoundationBangkok, ThailandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Massachusetts, Worcester
- Trial code
- NCT06576648
- Record updated
- 31 August 2026
- Original description
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-negative Thai vulnerable emerging adults (18-29 years).Read full original descriptionShow less
Optimizing Mobile Interventions to Overcome Stigma and Promote HIV Prevention
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-negative Thai vulnerable emerging adults (18-29 years).
Inclusion: Ages between 18 and 29 years; Male sex at birth; Self-identifies as women, transgender women or culturally identifies with the female spectrum; Laboratory-confirmed HIV-negative status; Self-reported recent history of condomless sex; Able to understand, read and speak Thai; Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month.
Exclusion: Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month; Have a serious cognitive or psychiatric problem compromising ability to provide informed consent; Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment); Currently enrolled in another HIV intervention study; Healthcare providers Inclusion criteria; Has provided HIV prevention or treatment services for TGW for at least one year Exclusion criteria; Self-reported recent history of condomless sex; Have a serious cognitive or psychiatric problem compromising ability to provide informed consent; Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment); Currently enrolled in another HIV intervention study; Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance); Laboratory-confirmed HIV-negative status; Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance); Age 18 or above; Ages between 18 and 29 years; None; Aim 2 (Pilot RCT) Transgender women Inclusion criteria; Male sex at birth; Self-identifies as women, transgender women or culturally identifies with the female spectrum; Able to understand, read and speak Thai.
Aim 1 (Formative Research and Beta-Testing) Transgender women.